01:52 PM EDT, 03/28/2025 (MT Newswires) -- Portage Biotech ( PRTG ) shares almost doubled amid heavy trading Friday after the company reported overnight "encouraging" efficacy data in a murine mesothelioma model with PORT-7 given as a single agent or combined with an anti-PD-1 antibody.

Over 27.2 million shares traded intraday versus a daily average of roughly 96,000.

Lexicon Pharmaceuticals ( LXRX ) said Friday that it signed an exclusive license agreement with Novo Nordisk ( NVO ) for LX9851, a drug targeting obesity and associated metabolic disorders.

Shares of Lexicon advanced 82% as intraday trading volume catapulted to over 366.3 million from a daily average of roughly 6.3 million.

DBV Technologies ( DBVT ) late Thursday disclosed financing of up to $306.9 million to fund a peanut allergy patch for children four to seven years old.

Shares climbed 40% as intraday trading volume surged to more than 20.2 million from a daily average of about 62,000.

Price: 9.46, Change: +4.73, Percent Change: +99.92